Hormonelle Fertilitätstherapie beim Mann · Kapitel 22 von 22

Quellenverzeichnis (Teil 2 von 2)

[s132] Muhammed Arif İBİŞ, Kaan AYDOS (2021): Evaluation of gonadotropin therapy in male infertility caused by idiopathic hypogonadotropic hypogonadism / İdiopatik hipogonadotropik hipogonadizm nedenlierkek infertilitesinde gonadotropin tedavisinindeğerlendirilmesi (deutsch: Bewertung der Gonadotropintherapie bei männlicher Infertilität durch idiopathischen hypogonadotropen Hypogonadismus). Androloji Bülteni. DOI: 10.24898/tandro.2021.53254

[s133] Kalkanli A, Akdere H, Cevik G et al. (2021): Hypergonadotropic Hypogonadism: Management of Infertility. Current pharmaceutical design. PMID: 33138760; DOI: 10.2174/1381612826666201102110456

[s134] Li S, Zhao Y, Nie M, Yang Y, Hao M, Mao J et al. (2021): Comparison of Clinical Characteristics and Spermatogenesis in CHH Patients Caused by PROKR2 and FGFR1 Mutations. Reproductive sciences (Thousand Oaks, Calif.) 28:3219-3227. PMID: 33983622; DOI: 10.1007/s43032-021-00609-z

[s135] Liu Y, Ren XY, Peng YG, Chen SK, Cheng XR, Qin M et al. (2021): Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism. Chinese medical journal 134:1152-1159. PMID: 33813517; DOI: 10.1097/cm9.0000000000001419

[s136] Ma W, Mao J, Nie M, Wang X, Zheng J, Liu Z et al. (2021): Gonadotropin Therapy Once a Week for Spermatogenesis in Hypogonadotropic Hypogonadism. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 27:1119-1127. PMID: 33915281; DOI: 10.1016/j.eprac.2021.04.009

[s137] Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ et al. (2021): Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertility and sterility. PMID: 33309062; DOI: 10.1016/j.fertnstert.2020.11.015

[s138] Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ et al. (2021): Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II. Fertility and sterility. PMID: 33309061; DOI: 10.1016/j.fertnstert.2020.11.016

[s139] Shah T, Nyirenda T, Shin D (2021): Efficacy of anastrozole in the treatment of hypogonadal, subfertile men with body mass index ≥25 kg/m2. Translational andrology and urology. PMID: 33850757; DOI: 10.21037/tau-20-919

[s140] Shiraishi K, Ohmi C, Matsuyama H. (2021): Patient-reported outcomes and biochemical alterations during hormonal therapy in men with hypogonadotropic hypogonadism who have finished infertility treatment. Endocrine journal 68:221-229. PMID: 33012744; DOI: 10.1507/endocrj.ej20-0365

[s141] Trinh TS, Hung NB, Hien LTT, Tuan NA, Pho DC, Dung QA et al. (2021): Evaluating the Combination of Human Chorionic Gonadotropin and Clomiphene Citrate in Treatment of Male Hypogonadotropic Hypogonadism: A Prospective Study. Research and reports in urology. PMID: 34164348; DOI: 10.2147/rru.s315056

[s142] Verdi A, Nasr-Esfahani MH, Forouzanfar M, Tavalaee M (2021): The Effect of Recombinant Human Follicle-Stimulating Hormone on Sperm Quality, Chromatin Status and Clinical Outcomes of Infertile Oligozoospermic Men Candidate for Intracytoplasmic Sperm Injection: A Randomized Clinical Trial. International journal of fertility & sterility. PMID: 33497040; DOI: 10.22074/ijfs.2021.6210

[s143] Wei C, Long G, Zhang Y, Wang T, Wang S, Liu J et al. (2021): Spermatogenesis of Male Patients with Congenital Hypogonadotropic Hypogonadism Receiving Pulsatile Gonadotropin-Releasing Hormone Therapy Versus Gonadotropin Therapy: A Systematic Review and Meta-Analysis. The world journal of men's health 39:654-665. PMID: 32777865; DOI: 10.5534/wjmh.200043

[s144] Yang C, Li P, Li Z (2021): Clinical application of aromatase inhibitors to treat male infertility. Human reproduction update. PMID: 34871401; DOI: 10.1093/humupd/dmab036

[s145] Yılmazel FK, Karabulut İ, Yılmaz AH et al. (2021): A review of hypogonadotropic hypogonadism cases followed up in our clinic in the last decade. Urologia. PMID: 31622170; DOI: 10.1177/0391560319882231

[s146] Zhang L, Gao Y, Du Q, Liu L, Li Y, Dey SK et al. (2021): Genetic Profiles and Three-year Follow-up Study of Chinese Males With Congenital Hypogonadotropic Hypogonadism. The journal of sexual medicine 18:1500-1510. PMID: 34348883; DOI: 10.1016/j.jsxm.2021.07.001

[s147] Aljuhayman A, Almardawi A, Fallatah M, Alhathal N (2020): Efficacy of follicle-stimulating hormone as a treatment of severe idiopathic oligospermia: A retrospective study. Urology annals. PMID: 32015621; DOI: 10.4103/ua.ua_37_19

[s148] Amer MK, Ahmed HEH, GamalEl Din SF et al. (2020): Evaluation of neoadjuvant gonadotropin administration with downregulation by testosterone prior to second time microsurgical testicular sperm extraction: A prospective case-control study. Urologia. PMID: 32323641; DOI: 10.1177/0391560320913401

[s149] An Q, Zhang K, Fu L, Guo Y, Zhang C, Ge Z et al. (2020): The impact of exogenous testosterone supplementation on spermatogenesis in a rat model of oligoasthenospermia. International journal of clinical and experimental pathology 13:1287-1299. PMID: 32661465

[s150] Bakhtyukov AA, Derkach KV, Gureev MA et al. (2020): Comparative Study of the Steroidogenic Effects of Human Chorionic Gonadotropin and Thieno[2,3-D]pyrimidine-Based Allosteric Agonist of Luteinizing Hormone Receptor in Young Adult, Aging and Diabetic Male Rats. International journal of molecular sciences. PMID: 33050653; DOI: 10.3390/ijms21207493

[s151] Chen Y, Sun T, Niu Y, Wang D, Xiong Z, Li C et al. (2020): Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment. The journal of sexual medicine 17:645-657. PMID: 32171629; DOI: 10.1016/j.jsxm.2020.01.011

[s152] De Rocco Ponce M, Foresta C, Rago R, Dal Lago A, Balercia G, Calogero AE et al. (2020): Use of Biosimilar Follicle-Stimulating Hormone in Asthenozoospermic Infertile Patients: A Multicentric Study. Journal of clinical medicine. PMID: 32423110; DOI: 10.3390/jcm9051478

[s153] Del Giudice F, Busetto GM, De Berardinis E, Sperduti I, Ferro M, Maggi M et al. (2020): A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility. Asian journal of andrology. PMID: 31621654; DOI: 10.4103/aja.aja_101_19

[s154] Derkach KV, Bakhtyukov AA, Romanova IV et al. (2020): The effect of metformin treatment on the basal and gonadotropin-stimulated steroidogenesis in male rats with type 2 diabetes mellitus. Andrologia. PMID: 32951228; DOI: 10.1111/and.13816

[s155] Fietz D, Pilatz A, Diemer T, Wagenlehner F, Bergmann M, Schuppe HC (2020): Excessive unilateral proliferation of spermatogonia in a patient with non-obstructive azoospermia - adverse effect of clomiphene citrate pre-treatment? Basic and clinical andrology. PMID: 32884817; DOI: 10.1186/s12610-020-00111-7

[s156] Hao M, Nie M, Yu BQ, Gao YJ, Wang X, Ma WL et al. (2020): Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients. Asian journal of andrology 22:390-395. PMID: 31464203; DOI: 10.4103/aja.aja_88_19

[s157] Keihani S, Wright LN, Alder NJ, Jiang J, Cheng PJ, Stoddard GJ et al. (2020): Baseline Gonadotropin Levels and Testosterone Response in Hypogonadal Men Treated With Clomiphene Citrate. Urology. PMID: 32353397; DOI: 10.1016/j.urology.2020.04.074

[s158] Li S, Zhao Y, Nie M, Ma W, Wang X, Ji W et al. (2020): Clinical Characteristics and Spermatogenesis in Patients with Congenital Hypogonadotropic Hypogonadism Caused by FGFR1 Mutations. International journal of endocrinology 2020:8873532. PMID: 33354214; DOI: 10.1155/2020/8873532

[s159] Mongioì LM, Condorelli RA, Alamo A, Cannarella R, Musso N, La Vignera S et al. (2020): Follicle-Stimulating Hormone Treatment and Male Idiopathic Infertility: Effects on Sperm Parameters and Oxidative Stress Indices according to FSHR c. 2039 A/G and c. -29 G/A Genotypes. Journal of clinical medicine. PMID: 32498268; DOI: 10.3390/jcm9061690

[s160] Ortaç M, Hıdır M, Çilesiz NC et al. (2020): Efficacy of follitropin-alpha versus human menopausal gonadotropin for male patients with congenital hypogonadotropic hypogonadism. Turkish journal of urology. PMID: 31905120; DOI: 10.5152/tud.2019.19177

[s161] Sun D, Jin B, Cai B, Deng W. (2020): Deep vein thrombosis in a nonobstructive azoospermia male taking tamoxifen: a rare case report. Translational andrology and urology 9:1769-1772. PMID: 32944537; DOI: 10.21037/tau-20-630

[s162] Xie ZT, Li KY, Weng ZW, Zhou SH. (2020): [Traditional Chinese therapy of tonifying the kidney and invigorating blood circulation reduces sperm DNA damage and improves natural pregnancy in infertile males]. (deutsch: Traditionelle chinesische Therapie (Niere stärken, Durchblutung fördern) senkt DNA-Schäden der Spermien und verbessert die natürliche Schwangerschaft bei unfruchtbaren Männern). Zhonghua nan ke xue = National journal of andrology 26:74-77. PMID: 33345481

[s163] Yu B, Nie M, Wu X, Mao J, Wang X, Ma W et al. (2020): [Efficacy and safety of letrozole in treatment of male children with disorders of sex development]. (deutsch: Wirksamkeit und Sicherheit von Letrozol bei männlichen Kindern mit Störungen der Geschlechtsentwicklung). Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 49:297-301. PMID: 32762157; DOI: 10.3785/j.issn.1008-9292.2020.04.02

[s164] Ameli M, Moghimian M, Saeb F, Bashtani E, Shokoohi M, Salimnejad R et al. (2019): The effect of clomiphene citrate and human chorionic gonadotropin on the expression of CatSper1, CatSper2, LHCGR, and SF1 genes, as well as the structural changes in testicular tissue of adult rats. Molecular reproduction and development. PMID: 31041823; DOI: 10.1002/mrd.23151

[s165] Amer MK, Ahmed AR, Abdel Hamid AA et al. (2019): Can spermatozoa be retrieved in non-obstructive azoospermic patients with high FSH level?: A retrospective cohort study. Andrologia. PMID: 30311269; DOI: 10.1111/and.13176

[s166] Bao YG, Zheng LW, Dai XW, Wu GJ. (2019): [Compound Amino Acid Capsules combined with clomiphene for severe oligospermia]. (deutsch: Kompakte Aminosäurekapseln kombiniert mit Clomifen bei schwerer Oligozoospermie). Zhonghua nan ke xue = National journal of andrology 25:811-814. PMID: 32233208

[s167] Cannarella R, Condorelli RA, Mongioì LM, Barbagallo F, Calogero AE, La Vignera S (2019): Effects of the selective estrogen receptor modulators for the treatment of male infertility: a systematic review and meta-analysis. Expert opinion on pharmacotherapy. PMID: 31120775; DOI: 10.1080/14656566.2019.1615057

[s168] Chen YW, Niu YH, Xu H, Wang DQ, Jiang HY, Pokhrel G et al. (2019): Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study. Asian journal of andrology. PMID: 30604694; DOI: 10.4103/aja.aja_107_18

[s169] Earl JA, Kim ED (2019): Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism. Expert review of endocrinology & metabolism. PMID: 31063005; DOI: 10.1080/17446651.2019.1612239

[s170] Lin J, Mao J, Wang X, Ma W, Hao M, Wu X. (2019): Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism. Medicine 98:e16616. PMID: 31374027; DOI: 10.1097/md.0000000000016616

[s171] Liu Z, Mao J, Xu H, Wang X, Huang B, Zheng J et al. (2019): Gonadotropin-Induced Spermatogenesis in CHH Patients with Cryptorchidism. International journal of endocrinology 2019:6743489. PMID: 31929795; DOI: 10.1155/2019/6743489

[s172] Ortac M, Hidir M, Salabas E et al. (2019): Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism. Asian journal of andrology. PMID: 31062720; DOI: 10.4103/aja.aja_6_19

[s173] Sadeghi S, Reza Talebi A, Shahedi A, Reza Moein Md M, Abbasi-Sarcheshmeh A (2019): Effects of different doses of tamoxifen on the sperm parameters and chromatin quality in mice: An experimental model. International journal of reproductive biomedicine. PMID: 31435602; DOI: 10.18502/ijrm.v17i4.4553

[s174] Sadeghi S, Talebi AR, Shahedi A, Moein MR, Abbasi-Sarcheshmeh A (2019): Effects of Tamoxifen on DNA Integrity in Mice. Journal of reproduction & infertility. PMID: 30859077

[s175] Song SH, Sung S, Her YS, Oh M, Shin DH, Lee J et al. (2019): Misuse of testosterone replacement therapy in men in infertile couples and its influence on infertility treatment. Clinical and experimental reproductive medicine 46:173-177. PMID: 31739658; DOI: 10.5653/cerm.2019.00290

[s176] Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K et al. (2019): Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease. Geburtshilfe und Frauenheilkunde. PMID: 31875859; DOI: 10.1055/a-1017-3478

[s177] Zhang L, Cai K, Wang Y, Ji W, Cheng Z, Chen G et al. (2019): The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men. American journal of men's health 13:1557988318818280. PMID: 30569789; DOI: 10.1177/1557988318818280

[s178] Zhao N, Lu XL, Li JT, Zhang JM. (2019): Treatment of idiopathic oligozoospermia with combined human chorionic gonadotropin/human menopausal gonadotrophin: A randomised, double-blinded, placebo-controlled clinical study. Andrologia 51:e13271. PMID: 30891813; DOI: 10.1111/and.13271

[s179] Babak J, Behruz F, Mohammadreza Y, Morteza FK (2018): The Effect of Human Chorionic Gonadotropin Therapy on Semen Parameters and Pregnancy Rate after Varicocelectomy. Current urology. PMID: 29593468; DOI: 10.1159/000447200

[s180] El Meliegy A, Motawi A, El Salam MAA (2018): Systematic review of hormone replacement therapy in the infertile man. Arab journal of urology. PMID: 29713545; DOI: 10.1016/j.aju.2017.11.011

[s181] Hu X, Ding Z, Hong Z, Zou Z, Feng Y, Zhu R et al. (2018): Spermatogenesis improved by suppressing the high level of endogenous gonadotropins in idiopathic non-obstructive azoospermia: a case control pilot study. Reproductive biology and endocrinology : RB&E 16:91. PMID: 30243299; DOI: 10.1186/s12958-018-0401-7

[s182] Kobayashi M, Hori T, Kawakami E. (2018): Therapeutic effects of oral clomiphene citrate in 2 dogs with low plasma testosterone levels and poor semen quality. The Journal of veterinary medical science 80:1233-1235. PMID: 29937459; DOI: 10.1292/jvms.18-0108

[s183] Mao JF, Wang X, Yu BQ, Gao YJ, Nie M, Wu XY. (2018): [Diagnosis and management of adult-onset idiopathic hypogonadotropic hypogonadism]. (deutsch: Diagnose und Management des idiopathischen hypogonadotropen Hypogonadismus mit Erwachsenenbeginn). Zhonghua yi xue za zhi 98:1597-1600. PMID: 29886652; DOI: 10.3760/cma.j.issn.0376-2491.2018.20.014

[s184] Yang L, Chen HS, Qu R, Zhang SX. (2018): [Diagnosis and treatment of idiopathic hypogonadotropic hypogonadism in males]. (deutsch: Diagnose und Behandlung des idiopathischen hypogonadotropen Hypogonadismus beim Mann). Zhonghua nan ke xue = National journal of andrology 24:744-747. PMID: 30173437

[s185] Bozhedomov VA, Lipatova NA, Bozhedomova GE et al. (2017): [Using L- and acetyl-L-carnintines in combination with clomiphene citrate and antioxidant complex for treating idiopathic male infertility: a prospective randomized trial]. (deutsch: Einsatz von L- und Acetyl-L-Carnitin in Kombination mit Clomifencitrat und einem Antioxidantienkomplex bei idiopathischer männlicher Infertilität: eine prospektive randomisierte Studie). Urologiia (Moscow, Russia : 1999). PMID: 28845935; DOI: 10.18565/urol.2017.3.22-32

[s186] Hu HR, Nie HC, Yang WM, Sun Y, Huang H, Xie FG. (2017): [Trigger effect of hMG and hCG in the treatment of unexplainable non-obstructive azoospermia]. (deutsch: Auslösewirkung von hMG und hCG bei der Behandlung unerklärlicher nichtobstruktiver Azoospermie). Zhonghua nan ke xue = National journal of andrology 23:813-816. PMID: 29726663

[s187] Kohn TP, Louis MR, Pickett SM, Lindgren MC, Kohn JR, Pastuszak AW et al. (2017): Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertility and sterility. PMID: 27855957; DOI: 10.1016/j.fertnstert.2016.10.004

[s188] Li T, Xie S, Tan Y, Xie ZP, Wang WR, Li H. (2017): [Mid-frequency transcutaneous electrical acupoint stimulation combined with tamoxifen for the treatment of oligoasthenozoospermia]. (deutsch: Mittelfrequente transkutane elektrische Akupunkturpunkt-Stimulation kombiniert mit Tamoxifen bei Oligoasthenozoospermie). Zhonghua nan ke xue = National journal of andrology 23:928-932. PMID: 29727545

[s189] Mao JF, Liu ZX, Nie M, Wang X, Xu HL, Huang BK et al. (2017): Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism. Asian journal of andrology 19:680-685. PMID: 28051040; DOI: 10.4103/1008-682x.193568

[s190] Oka S, Shiraishi K, Matsuyama H. (2017): Effects of human chorionic gonadotropin on testicular interstitial tissues in men with non-obstructive azoospermia. Andrology 5:232-239. PMID: 27860441; DOI: 10.1111/andr.12292

[s191] Shiraishi K, Matsuyama H. (2017): Gonadotoropin actions on spermatogenesis and hormonal therapies for spermatogenic disorders [Review]. Endocrine journal 64:123-131. PMID: 28100869; DOI: 10.1507/endocrj.ej17-0001

[s192] Bertrand-Delepine J, Leroy C, Rigot JM, Catteau-Jonard S, Dewailly D, Robin G (2016): [Stimulation of spermatogenesis: For whom? Why? How?] (deutsch: Stimulation der Spermatogenese: Für wen? Warum? Wie?). Gynecologie, obstetrique & fertilite. PMID: 27475410; DOI: 10.1016/j.gyobfe.2016.05.009

[s193] Chiba K, Enatsu N, Fujisawa M. (2016): Management of non-obstructive azoospermia. Reproductive medicine and biology 15:165-173. PMID: 29259433; DOI: 10.1007/s12522-016-0234-z

[s194] Ümit GÜL, Tahsin TURUNÇ (2016): The Effect of Human Chorionic Gonadotropin Treatment Before Testicular Sperm Extraction in Non-Obstructive Azoospermia / Non-Obstruktif Azoospermide Testiküler Sperm Ekstraksiyonu Öncesi Human Koryonik Gonadotropin Tedavisinin Etkisi (deutsch: Wirkung der Behandlung mit humanem Choriongonadotropin vor der testikulären Spermienextraktion bei nicht obstruktiver Azoospermie). Journal of Clinical and Analytical Medicine. ohne PMID/DOI, Link: https://search.trdizin.gov.tr/tr/yayin/detay/209664

[s195] Kim ED, McCullough A, Kaminetsky J (2016): Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU international. PMID: 26496621; DOI: 10.1111/bju.13337

[s196] Liu Z, Mao J, Wu X, Xu H, Wang X, Huang B et al. (2016): Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients. Medicine 95:e2867. PMID: 26945370; DOI: 10.1097/md.0000000000002867

[s197] Lu HL, Wang T, Xu H, Chen LP, Rao K, Yang J et al. (2016): [Secondary male hypogonadism induced by sellar space-occupying lesion: Clinical analysis of 22 cases]. (deutsch: Sekundärer männlicher Hypogonadismus durch raumfordernde Läsion der Sella: klinische Analyse von 22 Fällen). Zhonghua nan ke xue = National journal of andrology 22:704-709. PMID: 29019226

[s198] Rozhivanov RV, Kravtsova NS, Kurbatov DG (2016): [Stimulation of a spermatogenesis in men at a pathospermia and infertility]. (deutsch: Stimulation der Spermatogenese bei Männern mit Pathospermie und Infertilität). Urologiia (Moscow, Russia : 1999). PMID: 28247748

[s199] Shiraishi K, Ishikawa T, Watanabe N, Iwamoto T, Matsuyama H. (2016): Salvage hormonal therapy after failed microdissection testicular sperm extraction: A multi-institutional prospective study. International journal of urology : official journal of the Japanese Urological Association 23:496-500. PMID: 26989893; DOI: 10.1111/iju.13076

[s200] Ding YM, Zhang XJ, Li JP, Chen SS, Zhang RT, Tan WL et al. (2015): Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population. Clinical endocrinology. PMID: 25761129; DOI: 10.1111/cen.12770

[s201] ElSheikh MG, Hosny MB, Elshenoufy A et al. (2015): Combination of vitamin E and clomiphene citrate in treating patients with idiopathic oligoasthenozoospermia: A prospective, randomized trial. Andrology. PMID: 26235968; DOI: 10.1111/andr.12086

[s202] Huang B, Mao J, Xu H, Wang X, Liu Z, Nie M et al. (2015): [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism]. (deutsch: Spermatogenese unter pulsatiler GnRH-Infusion im Vergleich zur Gonadotropintherapie beim männlichen idiopathischen hypogonadotropen Hypogonadismus). Zhonghua yi xue za zhi 95:1568-1571. PMID: 26463603

[s203] Kobori Y, Suzuki K, Iwahata T, Shin T, Sato R, Nishio K et al. (2015): Hormonal therapy (hCG and rhFSH) for infertile men with adult-onset idiopathic hypogonadotropic hypogonadism. Systems biology in reproductive medicine 61:110-112. PMID: 25518839; DOI: 10.3109/19396368.2014.994789

[s204] Kobori Y, Suzuki K, Iwahata T, Shin T, Sato R, Nishio K et al. (2015): Induction of spermatogenesis by rhFSH for azoospermia due to spermatogenic dysfunction with maturation arrest: five case series. Systems biology in reproductive medicine 61:168-170. PMID: 25804205; DOI: 10.3109/19396368.2015.1024897

[s205] Santi D, Granata AR, Simoni M (2015): FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocrine connections. PMID: 26113521; DOI: 10.1530/ec-15-0050

[s206] Sato N, Hasegawa T, Hasegawa Y, Arisaka O, Ozono K, Amemiya S et al. (2015): Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols. Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 24:37-49. PMID: 26019400; DOI: 10.1297/cpe.24.37

[s207] Shiraishi K. (2015): Hormonal therapy for non-obstructive azoospermia: basic and clinical perspectives. Reproductive medicine and biology 14:65-72. PMID: 29259404; DOI: 10.1007/s12522-014-0193-1

[s208] Tang KF, Zhao YL, Ding SS, Wu QF, Wang XY, Shi JQ et al. (2015): Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia. Journal of Zhejiang University. Science. B 16:191-197. PMID: 25743120; DOI: 10.1631/jzus.b1400282

[s209] Zhang M, Tong G, Liu Y, Mu Y, Weng J, Xue Y et al. (2015): Sequential Versus Continual Purified Urinary FSH/hCG in Men With Idiopathic Hypogonadotropic Hypogonadism. The Journal of clinical endocrinology and metabolism 100:2449-2455. PMID: 25825944; DOI: 10.1210/jc.2014-3802

[s210] Gulino G, Stefanucci M, Antonucci M, Racioppi M, Sacco E, Pinto F et al. (2014): [Male infertility: non-surgical therapy] (deutsch: Männliche Infertilität: nicht-chirurgische Therapie). Urologia. PMID: 25198940; DOI: 10.5301/uro.5000087

[s211] Kato Y, Shiraishi K, Matsuyama H. (2014): Expression of testicular androgen receptor in non-obstructive azoospermia and its change after hormonal therapy. Andrology 2:734-740. PMID: 24919724; DOI: 10.1111/j.2047-2927.2014.00240.x

[s212] Kobayashi M, Hori T, Kawakami E. (2014): Efficacy of low-dose human chorionic gonadotropin therapy in dogs with spermatogenic dysfunction: a preliminary study. Reproduction in domestic animals = Zuchthygiene 49:E44-7. PMID: 25130649; DOI: 10.1111/rda.12366

[s213] Lejeune H, Lapoirie M, Brosse A, Cuzin B, Giscard d'Estaing S, Plotton I (2014): [Medical optimisation of sperm retrieval in non obstructive azoospermia] (deutsch: Medikamentöse Optimierung der Spermiengewinnung bei nicht-obstruktiver Azoospermie). Gynecologie, obstetrique & fertilite. PMID: 25153439; DOI: 10.1016/j.gyobfe.2014.07.023

[s214] Wiehle RD, Fontenot GK, Wike J, Hsu K, Nydell J, Lipshultz L et al. (2014): Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Fertility and sterility. PMID: 25044085; DOI: 10.1016/j.fertnstert.2014.06.004

[s215] Zagarskikh EIu, Labygina AV, Kurashova NA (2014): [Experience in the treatment of normogonadotropic infertility in men]. (deutsch: Erfahrung mit der Behandlung normogonadotroper Infertilität bei Männern). Urologiia (Moscow, Russia : 1999). PMID: 25807767

[s216] Zhao D, Pan L, Zhang F, Pan F, Ma J, Zhang X et al. (2014): Successful use of aromatase inhibitor letrozole in NOA with an elevated FSH level: a case report. Andrologia 46:456-457. PMID: 23803162; DOI: 10.1111/and.12122

[s217] Attia AM, Abou-Setta AM, Al-Inany HG (2013): Gonadotrophins for idiopathic male factor subfertility. The Cochrane database of systematic reviews. PMID: 23970458; DOI: 10.1002/14651858.cd005071.pub4

[s218] Aydogdu A, Bolu E, Sonmez A et al. (2013): Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3-year experience. Clinical endocrinology. PMID: 23278834; DOI: 10.1111/cen.12135

[s219] Bang JK, Lim JJ, Choi J, Won HJ, Yoon TK, Hong JY et al. (2013): Reversible infertility associated with testosterone therapy for symptomatic hypogonadism in infertile couple. Yonsei medical journal 54:702-706. PMID: 23549818; DOI: 10.3349/ymj.2013.54.3.702

[s220] Chua ME, Escusa KG, Luna S, Tapia LC, Dofitas B, Morales M (2013): Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis. Andrology. PMID: 23970453; DOI: 10.1111/j.2047-2927.2013.00107.x

[s221] Cruz-Navarro N (2013): [Testosterone deficit syndrome in fertile or subfertile men] (deutsch: Testosteronmangel-Syndrom bei fertilen oder subfertilen Männern). Archivos espanoles de urologia. PMID: 24047626

[s222] Gong W, Gao XC. (2013): [Clinical diagnosis and treatment of male Kallmann syndrome]. (deutsch: Klinische Diagnose und Behandlung des männlichen Kallmann-Syndroms). Zhonghua nan ke xue = National journal of andrology 19:1111-1114. PMID: 24432625

[s223] Kaminetsky J, Werner M, Fontenot G, Wiehle RD (2013): Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. The journal of sexual medicine. PMID: 23530575; DOI: 10.1111/jsm.12116

[s224] Shinjo E, Shiraishi K, Matsuyama H. (2013): The effect of human chorionic gonadotropin-based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non-obstructive azoospermia. Andrology 1:929-935. PMID: 24123916; DOI: 10.1111/j.2047-2927.2013.00141.x

[s225] Wiehle R, Cunningham GR, Pitteloud N, Wike J, Hsu K, Fontenot GK et al. (2013): Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics. BJU international. PMID: 23875626; DOI: 10.1111/bju.12363

[s226] Amirzargar MA, Yavangi M, Basiri A, Hosseini Moghaddam SM, Babbolhavaeji H, Amirzargar N et al. (2012): Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial. Iranian journal of reproductive medicine. PMID: 25246910

[s227] Gamidov CI, Ovchinnikov RI, Popova AIu et al. (2012): [Current approach to therapy for male infertility in patients with varicocele]. (deutsch: Aktuelle Therapieansätze bei männlicher Infertilität mit Varikozele). Terapevticheskii arkhiv. PMID: 23227502

[s228] Lu JC, Huang YF. (2012): [Diagnosis and treatment of idiopathic semen quality abnormalities]. (deutsch: Diagnose und Behandlung idiopathischer Samenqualitätsstörungen). Zhonghua nan ke xue = National journal of andrology 18:3-10. PMID: 22295841

[s229] Shiraishi K, Ohmi C, Shimabukuro T, Shimabukuro T, Matsuyama H. (2012): Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia. Human reproduction (Oxford, England) 27:331-339. PMID: 22128297; DOI: 10.1093/humrep/der404

[s230] Yang L, Zhang SX, Dong Q, Xiong ZB, Li X. (2012): Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. International urology and nephrology 44:393-399. PMID: 21989858; DOI: 10.1007/s11255-011-0065-0

[s231] Zhang X, Liang JH, Liang SK, Wei GQ, Zhu CH, Song WR et al. (2012): [Combination of compound Xuanju capsule and tamoxifen citrate for idiopathic oligozoospermia]. (deutsch: Kombination aus Xuanju-Kompaktkapsel und Tamoxifencitrat bei idiopathischer Oligozoospermie). Zhonghua nan ke xue = National journal of andrology 18:661-664. PMID: 22994054

[s232] Cavallini G, Beretta G, Biagiotti G (2011): Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH. Asian journal of andrology. PMID: 21706040; DOI: 10.1038/aja.2011.44

[s233] Ismet Faruk OZGUNER, Namık DELİBAŞ, Meltem ÖZGÜNER (2011): Tek taraflı inmemiş testis modelinde hcg tedavisi sonrası biyokimyasal ve histopatolojik değişiklikler / Biochemical and histopathological alterations in a unilateral cryptorchidism model after hcg treatment (deutsch: Biochemische und histopathologische Veränderungen nach hCG-Behandlung im Modell des einseitigen Hodenhochstands). Türkiye Çocuk Hastalıkları Dergisi. ohne PMID/DOI, Link: https://search.trdizin.gov.tr/tr/yayin/detay/143352

[s234] Saylam B, Efesoy O, Cayan S (2011): The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men. Fertility and sterility. PMID: 20934689; DOI: 10.1016/j.fertnstert.2010.09.021

[s235] Tang KF, Xing Y, Wu CY, Liu RZ, Wang XY, Xing JP. (2011): [Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia]. (deutsch: Tamoxifen kombiniert mit Coenzym Q10 bei idiopathischer Oligoasthenozoospermie). Zhonghua nan ke xue = National journal of andrology 17:615-618. PMID: 21823344

[s236] Bak CW, Song SH, Yoon TK, Lim JJ, Shin TE, Sung S. (2010): Natural course of idiopathic oligozoospermia: comparison of mild, moderate and severe forms. International journal of urology : official journal of the Japanese Urological Association 17:937-943. PMID: 20831771; DOI: 10.1111/j.1442-2042.2010.02628.x

[s237] Chen B, Zhang ZG, Wang HX, Wang YB, Hu K, Jin Y et al. (2010): [Standardized diagnosis and treatment of azoospermia: a report of 1027 cases]. (deutsch: Standardisierte Diagnose und Behandlung der Azoospermie: Bericht über 1027 Fälle). Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 42:409-412. PMID: 20721253

[s238] Ghanem H, Shaeer O, El-Segini A (2010): Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertility and sterility. PMID: 19268928; DOI: 10.1016/j.fertnstert.2009.01.117

[s239] Kliesch S (2010): [Testosterone and infertility] (deutsch: Testosteron und Infertilität). Der Urologe. Ausg. A. PMID: 20063086; DOI: 10.1007/s00120-009-2195-x

[s240] Koyama K, Masuda H, Inamoto T, Segawa N, Azuma H, Katsuoka Y. (2010): A successful conception by a shift from human menopausal gonadotropin therapy to therapy with recombinant human follicular-stimulating hormone for the treatment of male hypogonadotropic hypogonadism. Reproductive medicine and biology 9:57-60. PMID: 29699330; DOI: 10.1007/s12522-009-0035-8

[s241] M. Murat BAŞAR, Devrim TUĞLU (2009): İnfertil hastalarda aromataz inhibitörleri: kısa süreli izlemde serum ve seminal plazma testosteron and östradiol düzeylerine etkileri / Aromatase inhibitors in infertile patients: effects on seminal parameters, serum and seminal plasma testosterone levels, and estradiol levels during short-term follow-up (deutsch: Aromatasehemmer bei infertilen Patienten: Wirkungen auf Testosteron- und Östradiolspiegel in Serum und Seminalplasma bei kurzzeitiger Beobachtung). Turkish Journal of Medical Sciences. ohne PMID/DOI, Link: https://search.trdizin.gov.tr/tr/yayin/detay/93755

[s242] Cakan M, Aldemir M, Topcuoglu M et al. (2009): Role of testosterone/estradiol ratio in predicting the efficacy of tamoxifen citrate treatment in idiopathic oligoasthenoteratozoospermic men. Urologia internationalis. PMID: 19996653; DOI: 10.1159/000251186

[s243] Resorlu B, Abdulmajed MI, Kara C et al. (2009): Is intracytoplasmic sperm injection essential for the treatment of hypogonadotrophic hypogonadism? A comparison between idiopathic and secondary hypogonadotrophic hypogonadism. Human fertility (Cambridge, England). PMID: 19824804; DOI: 10.3109/14647270903331139

[s244] Ferhat ATEŞ, Kadir BAYKAL, Cüneyt ADAYENER et al. (2008): The influence of beta HCG treatment on fertility index in an experimental cryptorchidism model / Deneysel inmemiş testis modelinde beta HCG tedavisinin fertilite indeksi üzerindeki etkisi (deutsch: Einfluss der Beta-hCG-Behandlung auf den Fertilitätsindex im experimentellen Kryptorchismusmodell). Yeni Üroloji Dergisi. ohne PMID/DOI, Link: https://search.trdizin.gov.tr/tr/yayin/detay/88491

[s245] Attia AM, Al-Inany HG, Farquhar C, Proctor M (2007): Gonadotrophins for idiopathic male factor subfertility. The Cochrane database of systematic reviews. PMID: 17943837; DOI: 10.1002/14651858.cd005071.pub3

[s246] Fuat DEMİREL, M. Uğur ALTUĞ, Murat ÇAKAN et al. (2005): Partial isolated FSH deficiency / Parsiyel izole FSH eksikliği (İFDS) (deutsch: Partieller isolierter FSH-Mangel). Türk Fertilite Dergisi. ohne PMID/DOI, Link: https://search.trdizin.gov.tr/tr/yayin/detay/51387

[s247] Di FS, Cui YG, Jia Y. (2005): [The application of gonadotropin in treatment of male central hypogonadism]. (deutsch: Anwendung von Gonadotropin bei der Behandlung des zentralen Hypogonadismus beim Mann). Zhonghua nei ke za zhi 44:836-839. PMID: 16316564

[s248] Hussein A, Ozgok Y, Ross L, Niederberger C (2005): Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. Journal of andrology. PMID: 16291975; DOI: 10.2164/jandrol.04180

[s249] de Souza CA, Cunha Filho JS, Santos D, Gratão AA, Filippon L, Tedesco C et al. (2003): [Follicle stimulating hormone as predictor of mobile spermatozoa in testicular biopsy of azoospermic patients] (deutsch: FSH als Prädiktor für bewegliche Spermien in der Hodenbiopsie azoospermer Patienten). Revista da Associacao Medica Brasileira (1992). PMID: 12886394; DOI: 10.1590/s0104-42302003000200035

[s250] L. TAHMAZ, M. KİLCİLER, Y. ÖZGÖK et al. (2001): Oligospermik hastalarda yardımcı üreme teknikleri öncesinde sperm fonksiyonlarının düzenlenmesi / Improving the sperm parameters before assisted reproductive techniques for oligosoospermic patients (deutsch: Verbesserung der Spermienparameter vor assistierten Reproduktionstechniken bei Patienten mit Oligozoospermie). Türk Üroloji Dergisi/Turkish Journal of Urology. ohne PMID/DOI, Link: https://search.trdizin.gov.tr/tr/yayin/detay/16059

[s251] İlhan ÇELEBİ, A. Adil ESEN, Hatem KAZIMOĞLU et al. (2000): İdyopatik infertilitede klomifen sitrat tedavisinin yeri: İlk sonuçlar (deutsch: Der Stellenwert der Clomifencitrat-Behandlung bei idiopathischer Infertilität: erste Ergebnisse). Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi. ohne PMID/DOI, Link: https://search.trdizin.gov.tr/tr/yayin/detay/10413

[s252] Devoto E, Madariaga M, Lioi X (2000): [Causes of male infertility. The contribution of the endocrine factor] (deutsch: Ursachen männlicher Infertilität. Der Beitrag des endokrinen Faktors). Revista medica de Chile. PMID: 10962887; DOI: 10.4067/s0034-98872000000200008

[s253] Turner KJ, Morley M, Atanassova N, Swanston ID, Sharpe RM (2000): Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility. The Journal of endocrinology. PMID: 10657858; DOI: 10.1677/joe.0.1640225

[s254] Tachiki H, Ito N, Maruta H, Kumamoto Y, Tsukamoto T. (1998): Testicular findings, endocrine features and therapeutic responses of men with acquired hypogonadotropic hypogonadism. International journal of urology : official journal of the Japanese Urological Association 5:80-85. PMID: 9535606; DOI: 10.1111/j.1442-2042.1998.tb00244.x

[s255] Coppola A (1997): [Endocrine diseases and male infertility] (deutsch: Endokrine Erkrankungen und männliche Infertilität). Minerva medica. PMID: 9411312

[s256] Fuse H, Akashi T, Kazama T, Katayama T. (1996): Gonadotropin therapy in males with hypogonadotropic hypogonadism: factors affecting induction of spermatogenesis after gonadotropin replacement. International urology and nephrology 28:367-374. PMID: 8899478; DOI: 10.1007/bf02550500

[s257] Tachiki H, Kumamoto Y, Itoh N, Maruta H, Tsukamoto T. (1995): [Testicular findings, endocrine features and therapeutic responses of men with idiopathic hypogonadotropic hypogonadism]. (deutsch: Hodenbefunde, endokrine Merkmale und Therapieansprechen bei Männern mit idiopathischem hypogonadotropem Hypogonadismus). Nihon Naibunpi Gakkai zasshi 71:605-622. PMID: 7796925; DOI: 10.1507/endocrine1927.71.4_605

[s258] Huang CC, Huang HS. (1994): Successful treatment of male infertility due to hypogonadotropic hypogonadism--report of three cases. Changgeng yi xue za zhi 17:78-84. PMID: 8205503

[s259] Kung AW, Zhong YY, Lam KS, Wang C. (1994): Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism. International journal of andrology 17:241-247. PMID: 7698849; DOI: 10.1111/j.1365-2605.1994.tb01249.x

[s260] Conte D, Romanelli F, Isidori A (1990): [Treatment of male idiopathic sterility with gonadotropin] (deutsch: Behandlung der idiopathischen männlichen Sterilität mit Gonadotropin). Minerva endocrinologica. PMID: 2274020

[s261] Takagi Y, Kumamoto Y, Itoh N, Nanbu A, Tachiki H, Mikuma N et al. (1990): 男子不妊症の治療学的検討 Clomiphene Citrate 投与による精漿 transferrin 上昇度と Sperm Count 改善度との関連性 (deutsch: Therapeutische Untersuchung der männlichen Unfruchtbarkeit: Zusammenhang zwischen dem Anstieg des Transferrins im Seminalplasma unter Clomifencitrat und der Verbesserung der Spermienzahl). The Japanese Journal of Urology (日本泌尿器科学会雑誌) 81(7). DOI: 10.5980/jpnjurol1989.81.1017

[s262] Namiki M, Nakamura M, Okuyama A, Sonoda T, Doi Y, Matsui T et al. (1988): [Testicular follicle-stimulating hormone receptors and effectiveness of human menopausal gonadotropin-human chorionic gonadotropin treatment in idiopathic male infertility]. (deutsch: Testikuläre FSH-Rezeptoren und Wirksamkeit der Behandlung mit humanem Menopausengonadotropin und hCG bei idiopathischer männlicher Unfruchtbarkeit). Hinyokika kiyo. Acta urologica Japonica 34:957-961. PMID: 3146922

[s263] Lunenfeld B (1984): [Hormone therapy of male infertility] (deutsch: Hormontherapie der männlichen Infertilität). Wiener medizinische Wochenschrift (1946). PMID: 6437086

Alle Kapitel und Anhänge (26)
  1. Das Wichtigste in Kürze
  2. Aufbau und Methodik dieser Studie
  3. Hintergrund
  4. Übersicht der Metaanalysen und systematischen Übersichten bis Hypogonadotroper Hypogonadismus (HH)
  5. Hypogonadismus (Testosteronmangel) und SERM: indirekt fertilitätsrelevante Übersichten bis Zusammenschau der Metaanalysen und Übersichten
  6. Hypogonadotroper Hypogonadismus: westliche, australische und türkische Kohorten bis Hypogonadotroper Hypogonadismus: Japan, Korea, Taiwan und weitere Länder
  7. Nicht-obstruktive Azoospermie: Hormonvorbehandlung und Salvage-Therapie bei Beobachtungsstudien bis Idiopathische und unerklärte Oligo-, Astheno- und Teratozoospermie: Aromatasehemmer
  8. Idiopathische Oligo-, Astheno- und Teratozoospermie: FSH, hMG, hCG und Kombinationen bis Zusammenschau der Beobachtungsstudien
  9. Vorbemerkung zu Grundlage und Grenzen bis Clomifen, Tamoxifen und Enclomiphen
  10. Aromatasehemmer (Letrozol, Anastrozol, Testolacton) bis Hypogonadotroper Hypogonadismus: Gonadotropine und GnRH-Pumpe
  11. Nicht-obstruktive Azoospermie: Hormonvorbehandlung vor der Spermiengewinnung bis Einordnung der Studienlage und Besonderheiten der Quellenräume
  12. Mechanismen und biologische Plausibilität
  13. Dosis-Wirkung, Subgruppen und Reversibilität
  14. Englisch bis Chinesisch
  15. Japanisch bis Türkisch
  16. Widersprüche und ihre mögliche Erklärung
  17. Limitationen der Evidenz
  18. Offene Forschungsfragen
  19. Praktische Einordnung
  20. Glossar
  21. Quellenverzeichnis (Teil 1 von 2)
  22. Quellenverzeichnis (Teil 2 von 2)
  23. Diagramme
  24. Quellen s01–s133
  25. Quellen s134–s263
  26. Prüfprotokoll der Quellenkontrolle